 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This price move could be a signal that INGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

Inogen (INGN, $5.1) price may climb as it broke lower Bollinger Band on Dec 05, 2023

BNP Paribas Arbitrage SNC increased its holdings in Inogen, Inc. (NASDAQ:INGN  Free Report) by 227.4% during the 2nd quarter, Holdings Channel reports. The firm owned 53,613 shares of the...

BNP Paribas Arbitrage SNC Purchases 37,236 Shares of Inogen, Inc. (NASDAQ:INGN)

This indicator may be signaling that INGN's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Inogen (INGN, $5.68) entered Downtrend as Momentum indicator drops below 0 level on Dec 04, 2023

This is a Bearish indicator signaling INGN's price could decline from here. Traders may explore shorting the stock or put options...

Inogen (INGN, $5.68) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 4, 2023

This is a signal that INGN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Inogen (INGN, $6.03) RSI Indicator left the overbought zone on November 24, 2023

Inogen (INGN, $5.62) RSI Indicator left the overbought zone on November 16, 2023

Inogen (INGN, $5.78) RSI Indicator left the overbought zone on November 15, 2023

Investors considering a purchase of Inogen, Inc (INGN) stock, but tentative about paying the going market price of 5.71/share, might benefit from considering selling puts among the alternative...

Commit To Buy Inogen At $5, Earn 13.3% Annualized Using Options

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Kevin...

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following...

Inogen to Present at Upcoming Investor Conferences in November 2023

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Watchers	1,364
52-Wk Low	$4.13
52-Wk High	$26.11

Market Cap	$132.39M
Volume (M)	1,534.00
52-Wk High	$26.11
52-Wk Low	$4.13

INGN Inogen Inc

About

Feed

News

Sentiment

Earnings

Fundamentals